Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement

Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement

Diffuse large B-cell lymphoma (DLBCL) with extra nodal skeletal involvement is rare. It is currently unclear whether these lymphomas should be treated in the same manner as those without skeletal involvement. We retrospectively analyzed the impact of combining high-dose methotrexate (HD-MTX) with an...

Full description

Bibliographic Details
Main Authors: Mélanie Mercier, Corentin Orvain, Laurianne Drieu La Rochelle, Tony Marchand, Christopher Nunes Gomes, Aurélien Giltat, Jérôme Paillassa, Aline Clavert, Jonathan Farhi, Marie-Christine Rousselet, Emmanuel Gyan, Roch Houot, Marie-Pierre Moles-Moreau, Mathilde Hunault-Berger
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
lymphoma
bone
skeletal
high-dose methotrexate
Online Access:https://www.mdpi.com/2072-6694/13/12/2945

Internet

https://www.mdpi.com/2072-6694/13/12/2945

Similar Items